🇺🇸 FDA

Intelligence Platform

Patents

Browse 710 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10123979

Methods of treating developmental disorders with biguanides

OVID THERAPEUTICS INC. · Granted Tue Nov 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10100020

Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfoldi

United Kingdom Research and Innovation · Granted Tue Oct 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10081811

Organic compositions to treat Beta-ENaC-related diseases

Arrowhead Pharmaceuticals, Inc. · Granted Tue Sep 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10076527

Standardized extract and its use in the manufacture of a medicament

Botanic Century (Beijing) Co. Ltd. · Granted Tue Sep 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10070631

Rodents having a humanized TMPRSS gene

REGENERON PHARMACEUTICALS, INC. · Granted Tue Sep 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10070632

Rodents having a humanized TMPRSS gene

REGENERON PHARMACEUTICALS, INC. · Granted Tue Sep 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10039908

Swallowable drug delivery device and method of delivery

Rani Therapeutics, LLC · Granted Tue Aug 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10035846

Humanized pertussis antibodies and uses thereof

The Board of Regents of the University of Texas System · Granted Tue Jul 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10029080

Method for delivering exenatide into a lumen of the intestinal tract using a swallowable d

Rani Therapeutics, LLC · Granted Tue Jul 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10023862

Organic compositions to treat beta-catenin-related diseases

Arrowhead Pharmaceuticals, Inc. · Granted Tue Jul 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10017580

Humanized anti-Tn-MUC1 antibodies and their conjugates

ADC THERAPEUTICS SA · Granted Tue Jul 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10016474

Plant extract, compositions containing same, method of extraction and uses thereof

Botanic Century (Beijing) Co. Ltd. · Granted Tue Jul 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10015953

Non-human animals having a humanized cluster of differentiation 47 gene

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jul 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10011562

Long-chain dimethylaniline derivative compounds, their preparation methods, self-assembled

WEST CHINA HOSPITAL, SICHUAN UNIVERSITY · Granted Tue Jul 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10004702

Linear guanidine derivatives, methods of preparation and uses thereof

LEAD DISCOVERY SIENA S.R.L. · Granted Tue Jun 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10006080

High-selectivity contact activation inhibitor based on infestin-4

OBSCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYU “GEMATOLOGICHESKAYA KORPORATSIYA” · Granted Tue Jun 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10004783

Method for delivering pramlintide into a lumen of the intestinal tract using a swallowable

Rani Therapeutics, LLC · Granted Tue Jun 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9999613

2H-chromene derivatives as analgesic agents

OBSHESTVO S OGRANICHENNOI OTVETSVENNOSTJU “LEOFORS” · Granted Tue Jun 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9986724

Genetically modified non-human animals and methods of use thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jun 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9974796

Inhibitors of the plasmodial surface anion channel as antimalarials

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9969709

Guanidinobenzoic acid ester compound

Takeda Pharmaceutical Company Limited · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9969790

Compositions and methods for immunomodulation in an organism

UNIVERSITY OF CONNECTICUT · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9956178

Methods for delivering insulin preparations into a lumen of the intestinal tract using a s

Rani Therapeutics, LLC · Granted Tue May 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9949962

Pharmaceutical composition comprising glutarimide derivatives and use thereof in the treat

OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted